investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
1 of 3 Interdisciplinary Collaboratory for Enhancing Translational Therapeutics Utilizing Biologically, Immunologically, and Metabollically Relevant Models of Breast Cancer
William J Murphy
5 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Michael S Kent
University of California, Davis
Davis, United States
Ellen E Sparger
University of California, Davis
Davis, United States
David M Rocke
University of California, Davis
Davis, United States
Arta M Monjazeb
University of California, Davis
Davis, United States
Alexander D Borowsky
University of California, Davis
Davis, United States
William J Murphy
University of California, Davis
Davis, United States
Related projects
W Todd Miller
Substrate Specificity of Non-receptor Tyrosine Kinases
Breast
Condeelis S John
Tumor microenvironments determing migration, dissemination and dormancy
Breast
Philip Tofilon
Radiation-induced translational control of gene expression
Breast
Radiation Oncology
Katarzyna Slowinska
Rigid-rod Peptides as Nanocarriers for Delivery of Cancer Drugs
Breast
Marie C. Lee
Development of the Malignancy-Risk Gene Signature Assay for Predicting Breast Cancer Risk
Breast
Laura Alice Stransky
Elucidating the mechanism of mTORC1 activation by amino acids
Breast
Pathology
Leonard Neckers
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction
Breast
Ana Soto
Mechanism of developmental toxicity of Bisphenol-A
Breast
Pathology
Fraser Symmans
Development of A Predictive Genomic Diagnostic Test for Survival Benefit from Everolimus (mTOR Inhibitor) Combined with Endocrine Therapy for Metastatic HR+/HER- Breast Cancer
Breast